Granulomatous interstitial nephritis treated with a tumour necrosis factor-α inhibitor

Nephrology Dialysis Transplantation

Volumn 21, Issue 8, 2006, Pages 2311-2314

  Tomlinson, Laurie ^a   Davies, Kevin ^b   Wright, David A ^a   Holt, Stephen ^a  

^a ROYAL SUSSEX COUNTY HOSPITAL   (United Kingdom)

^b UNIVERSITY OF SUSSEX   (United Kingdom)

Author keywords

Interstitial nephritis; Tumour necrosis factor

Indexed keywords

CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; INFLIXIMAB; PREDNISOLONE; TACROLIMUS; TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; CORTICOSTEROID THERAPY; DELAYED PUBERTY; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG DOSE REDUCTION; DRUG MEGADOSE; EDEMA; FOLLOW UP; HUMAN; HYPERTENSION; INTERSTITIAL NEPHRITIS; KIDNEY BIOPSY; KIDNEY DYSFUNCTION; KIDNEY FUNCTION; MALE; MINIMAL CHANGE GLOMERULONEPHRITIS; NEPHROTIC SYNDROME; NEPHROTOXICITY; OBESITY; PRIORITY JOURNAL; PROTEINURIA; RELAPSE; REMISSION; SHORT STATURE; TREATMENT OUTCOME;

ANTIBODIES, MONOCLONAL; CHILD, PRESCHOOL; CYCLOSPORINE; DIAGNOSTIC ERRORS; DWARFISM; GRANULOMA; HEMATURIA; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; NEPHRITIS, INTERSTITIAL; NEPHROSIS, LIPOID; NEPHROTIC SYNDROME; OBESITY; PREDNISOLONE; PROTEINURIA; PUBERTY, DELAYED; RECURRENCE; REMISSION INDUCTION; TACROLIMUS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33748037367     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfl018     Document Type: Article

References (19)

1. Mignon F, Mery JPH, Mougenot B. Granulomatous interstitial nephritis. Adv Nephrol 1984; 13: 219-245
2. Robson MG, Banerjee D, Hopster D, Cairns, HS. Seven cases of granulomatous interstitial nephritis in the absence of extrarenal sarcoid. Nephrol Dial Transplant 2003; 18: 280-284
3. Miyoshi KI, Okura T, Manabe S, Watanabe S, Fukuoka T, Higaki J. Granulomatous interstitial nephritis due to isolated renal sarcoidosis. Clin Exp Nephrol 2004; 8: 279-282
4. Moller DR. Treatment of sarcoidosis - from a basic science point of view. J Int Medicine 2003; 253: 31-40
5. Pritchard C, Nadarajah K. Tumour necrosis factor α inhibitor treatment for sarcoidosis refractory to conventional treatments: A report of five patients. Ann Rheum Dis 2004; 63: 318-320
6. Yee AMF, Pochapin MB. Treatment of complicated sarcoidosis with infliximab anti-tumour necrosis factor-α therapy. Ann Intern Med 2001; 135: 27-31
7. Ulbricht KU, Stoll M, Bierwith J, Witte T, Schmidt RE. Successful tumour necrosis factor-α blockade treatment in therapy-resistant sarcoidosis. Arth and Rheum 2003; 12: 3542-3543
8. Thumfart J, Müller D, Rudolph B, Zimmering M, Querfeld U, Haffner D. Isolated sarcoid granulomatous interstitial nephritis responding to infliximab therapy. Am J Kidney Dis 2004; 45: 411-414
9. Khan IH, Simpson JG, Catto GR, MacLeod AM. Membranous nephropathy and granulomatous interstitial nephritis in sarcoidosis. Nephron 1994; 66:459-461
10. Toda T, Kimoto S, Nishio Y, Ehara T, Sasaki S. Sarcoidosis with membranous nephropathy and granulomatous interstitial nephritis. Intern Med 1999; 38: 882-886
11. Richmond JM, Chambers B, D'Apice AJ, Whitworth JA, Kincaid-Smith P. Renal disease and sarcoidosis. Med J Aust 1981; 2: 36-37
12. North-Coombes JD, Healy GF, Cochrane J. Sarcoid-associated minimal change disease: A case report. J S C Med Assoc 1998; 94: 351-353
13. Nishimoto A, Tomiyoshi Y, Sakemi T et al. Simultaneous occurrence of minimal change glomerular disease, sarcoidosis and Hashimoto's thyroiditis. Am J Nephrol 2000; 20: 425-A28
14. Fasano MB, Sullivan KE, Sarpong SB et al. Sarcoidosis and common variable immunodeficiency. Report of 8 cases and review of the literature. Medicine 1996; 75: 251-261
15. Viero RM, Cavallo T. Granulomatous interstitial nephritis. Hum Pathol 1995; 26: 1347-1353
16. Longcope WT, Freiman DG. A study of sarcoidosis based on a combined investigation of 160 cases including 30 autopsies from the Johns Hopkins Hospital and Massachusetts General Hospital. Medicine 1952; 31:132-140
17. Mukhtyar C, Luqmani R. Current state of tumour necrosis factor {alpha} blockade in Wegener's granulomatosis. Ann Rheum Dis 2005; 64 [Suppl 4]: iv31-iv36
18. Aringer M, Graninger WB, Steiner G, Smolen JS. Safety and efficacy of tumor necrosis factor alpha blockade in systemic lupus erythematosus: An open-label study. Arthritis Rheum 2004; 50: 3161-3169
19. Fiehn C, Andrassy K. Case number 29: Hitting three with one strike: rapid improvement of psoriatic arthritis, psoriatic erythroderma, and secondary renal amyloidosis by treatment with infliximab (Remicade). Ann Rheum Dis 2004; 63: 232